...BRCA2, FANCA, FANCD2, RAD51) were overexpressed in tumour.,Mesothelioma resistance to therapy is reflected in the gene p...
...BRCA2 (n=43) MMR (MLH1, MSH2 MSH6) (n=31) and CDKN2A (n=15) genes in comparison with population based control families (...
...BRCA2 germline mutations. We aim to detect genetic variants associated with breast cancer susceptibility in Spain.,Withi...
...BRCA2 mutations (BRCA+) were selected from the Royal Marsden Hospital clinical genetics database and matched (1:2) with ...
...BRCA2 mutation carriers (45 yrs) and women tested negative for BRCA1 and BRCA2 mutations (46 yrs) as well as sporadic br...
...BRCA2 genes account for the majority of hereditary breast and ovarian cancer. Various risk assessment models are availab...
...BRCA2 mutations were found in our population. Further research on the spectrum of the mutations in Chinese will allow th...
...BRCA2 mutation is causatively related to an individual breast cancer. The aim of this study was to determine in an unsel...
...BRCA2, TP53, and CHEK2 mutation analysis.,Of 902 women submitted to GCRA, 214 (23.7%) women from 183 families had pedigr...
...BRCA2 or by abnormalities in the Fanconi Anemia pathway. In addition, the recently discovered oncogene EMSY is amplified...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
